Allogene Therapeutics Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for Allogene Therapeutics stock have an average target of 8.27, with a low estimate of 4.00 and a high estimate of 14. The average target predicts an increase of 221.79% from the current stock price of 2.57.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$8.27	$8.00	$14
Change	+55.64%	+221.79%	+211.28%	+444.75%

* Price targets were last updated on Jan 9, 2026.

Analyst Ratings

The average analyst rating for Allogene Therapeutics stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	4	4	4	5	5	5
Buy	6	6	6	6	6	6
Hold	1	1	1	0	0	0
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	12	12	12	12	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Reni Benjamin Citizens	Citizens	Hold → Buy Upgrades $5	Hold → Buy	Upgrades	$5	+94.55%	Jan 9, 2026
Michael Yee UBS	UBS	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+211.28%	Jan 7, 2026
Brian Cheng JP Morgan	JP Morgan	Hold → Sell Downgrades n/a	Hold → Sell	Downgrades	n/a	n/a	Oct 10, 2025
Reni Benjamin JMP Securities	JMP Securities	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Aug 4, 2025
Brian Cheng JP Morgan	JP Morgan	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Aug 4, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 22.00K

Revenue Next Year

18.54K

EPS This Year

-0.96

from -1.32

EPS Next Year

-0.89

from -0.96

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	114.09M	156.00K	95.00K	22.00K	-	18.54K
Revenue Growth	-	-	-99.86%	-39.10%	-76.84%	-	-
EPS	-2.63	-1.34	-2.38	-2.09	-1.32	-0.96	-0.89
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	18	18

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	105,000
Avg	n/a	18,544
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-0.90	-0.45
Avg	-0.96	-0.89
Low	-1.18	-1.44

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.